EKF Diagnostics Holdings
plc
("EKF" or
the "Company")
Trading
Update
EKF Diagnostics Holdings
plc (AIM: EKF), the AIM-listed global
diagnostics business, provides an unaudited
trading update for the year ended 31 December 2023 ("FY
2023").
The Company expects to report
full-year revenues and adjusted
EBITDA1 in-line with management
expectations, reflecting continued steady growth from the
Point-of-Care division and β-HB sales.
Cash, net of bank borrowings, as at 31 December 2023, was
£4.4m.
Good progress continues to be made
in the Life Sciences division's
fermentation capacity expansion. Purchase
orders for precision fermentation services using the new facility
have been received and the Company continues to onboard a number of
customers. The Board anticipates that a steady build-up of revenues
generated from the new fermentation capacity through 2024,
alongside maintained growth across Point-of-Care and
β-HB sales.
EKF will announce its FY 2023
results in late March 2024 and provide further insight to expected
performance for the current financial year at that time.
1Earnings before interest,
tax, depreciation and amortisation, excluding exceptional items and
share based payments.
|
EKF
Diagnostics Holdings plc
|
www.ekfdiagnostics.com
|
|
Julian Baines, Executive Chair
/ Stephen Young, CFO
|
Tel:
+44 (0)29 2071
0570
|
|
|
|
|
Singer Capital Markets (Nominated
Adviser & Broker)
|
Tel: +44
(0)20 7496 3000
|
|
Aubrey Powell / Oliver
Platts
|
|
|
|
|
|
Walbrook PR Limited
|
Tel: +44 (0)20 7933 8780
or ekf@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
Mob: +44
(0)7980 541 893 / +44 (0)7407 804
654
|
|
|
|
| |
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global
diagnostics business focussed on:
·
Point-of-Care analysers in the
key areas of Hematology and Diabetes, as well as Central Laboratory
products including clinical chemistry reagents, analysers and
centrifuges
·
Life
Sciences services provide specialist
manufacture of enzymes and custom products for use in diagnostic,
food and industrial applications, as well as other higher value
Contract Manufacturing services
EKF has headquarters in Penarth
(near Cardiff) and operates five manufacturing sites across the US
and Germany, selling into over 120 countries world-wide.